OPDUALAG conc perf flac 20 ml
7680686090019
CH-68609
L01FY02
07.16.1.
Reimbursement limitations:
OPDUALAG.01
OPDUALAG est indiqué pour le traitement de première ligne des adultes atteint·e·s de mélanome non …
1 / 3
google
Details
- Product number
- 6860901
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- relatlimabum 80 mg, nivolumabum 240 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, acidum penteticum, aqua ad iniectabile ad solutionem pro 20 ml.
Articles (1)
Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml), Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
240.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 6907.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2024
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 68609
- Drug name
- Opdualag, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FY02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/12/2022
- Authorization expiration date
- 22/12/2027
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OPDUALAG conc perf flac 20 ml
- Description (DE)
- OPDUALAG Inf Konz Durchstf 20 ml
- Market launch
- 23/12/2022
- Narcotic (BTM)
- No